RT Journal Article
SR Electronic
T1 Innovative therapeutic strategy for B-cell malignancies that combines obinutuzumab and cytokine-induced killer cells
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002475
DO 10.1136/jitc-2021-002475
VO 9
IS 7
A1 Dalla Pietà, Anna
A1 Cappuzzello, Elisa
A1 Palmerini, Pierangela
A1 Ventura, Annavera
A1 Visentin, Andrea
A1 Astori, Giuseppe
A1 Chieregato, Katia
A1 Mozzo, Valentina
A1 Perbellini, Omar
A1 Tisi, Maria Chiara
A1 Trentin, Livio
A1 Visco, Carlo
A1 Ruggeri, Marco
A1 Sommaggio, Roberta
A1 Rosato, Antonio
YR 2021
UL http://jitc.bmj.com/content/9/7/e002475.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.